CPSF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.568000E-01
Normal-vs-Stage2
9.539600E-01
Normal-vs-Stage3
1.169210E-01
Normal-vs-Stage4
4.675800E-01
Stage1-vs-Stage2
7.551400E-01
Stage1-vs-Stage3
2.488300E-02
Stage1-vs-Stage4
4.190000E-01
Stage2-vs-Stage3
7.399700E-02
Stage2-vs-Stage4
1.906790E-01
Stage3-vs-Stage4
6.814100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.328000E-01
Normal-vs-AfricanAmerican
8.247600E-01
Normal-vs-Asian
6.934000E-01
Caucasian-vs-AfricanAmerican
6.090800E-01
Caucasian-vs-Asian
2.274600E-01
AfricanAmerican-vs-Asian
7.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.683400E-01
Normal-vs-Female
9.272800E-01
Male-vs-Female
8.246000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.936000E-01
Normal-vs-Age(41-60Yrs)
6.016200E-01
Normal-vs-Age(61-80Yrs)
8.495400E-01
Normal-vs-Age(81-100Yrs)
9.763600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.877600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.452600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.694800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.835400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.005200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.825600E-01
Normal-vs-Daily Drinker
5.976400E-01
Normal-vs-Weekly Drinker
7.642600E-01
Normal-vs-Occasional Drinker
5.331000E-01
Normal-vs-Social Drinker
6.348000E-01
Non Drinker-vs-Daily Drinker
6.390400E-01
Non Drinker-vs-Weekly Drinker
9.391400E-01
Non Drinker-vs-Occasional Drinker
7.224400E-02
Non Drinker-vs-Social Drinker
1.371620E-01
Daily Drinker-vs-Weekly Drinker
7.530200E-01
Daily Drinker-vs-Occasional Drinker
2.994000E-02
Daily Drinker-vs-Social Drinker
6.976200E-02
Weekly Drinker-vs-Occasional Drinker
1.180620E-01
Weekly Drinker-vs-Social Drinker
2.004400E-01
Occasional Drinker-vs-Social Drinker
9.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.961630E-01
Normal-vs-Grade 2
7.083700E-02
Normal-vs-Grade 3
4.851800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.308000E-01
Grade 1-vs-Grade 3
7.495600E-02
Grade 1-vs-Grade 4
1.961630E-01
Grade 2-vs-Grade 3
1.831150E-01
Grade 2-vs-Grade 4
7.083700E-02
Grade 3-vs-Grade 4
4.851800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.756000E-01
Normal-vs-NonDiabetic
9.441400E-01
Diabetic-vs-NonDiabetic
7.937400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.449800E-01
Normal-vs-NoPancreatitis
9.771600E-01
Pancreatitis-vs-NoPancreatitis
1.257020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.358600E-01
Normal-vs-N1
8.748800E-01
N0-vs-N1
4.066200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.435000E-01
Normal-vs-TP53-NonMutant
9.905600E-01
TP53-Mutant-vs-TP53-NonMutant
2.798300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
